DXCM FINANCIAL STATEMENTS

DexCom Inc — balance sheet, income statement and cash flow trends

DXCMDexCom Inc

🇺🇸 USA · US · Healthcare · Medical Devices

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue4.8 B $+16.1%

Gross Profit3 B $+20.8%

Operating Income1 B $+63.4%

EBITDA1.5 B $+51.4%

Net Income930.4 M $+73.8%

Peer Comparison· Medical Devices

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
DXCM	16.1%	61.8%	30.6%	19.3%
PHIA	-1.9%	45.2%	15.4%	5.5%
SHL	-0.3%	38.0%	19.1%	9.1%
COH	2.0%	73.0%	24.0%	14.6%
4DX	-26.0%	-396.6%	-818.8%	-3,684.6%
Industry median	7.4%	58.9%	5.2%	-5.7%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
DXCM	16.1%	61.8%	30.6%	19.3%
GEHC	0.8%	42.5%	17.0%	7.5%
STE	8.7%	44.2%	30.8%	13.2%
ZBH	9.2%	70.0%	26.2%	9.1%
EW	13.8%	78.0%	22.5%	17.3%
PEN	17.3%	67.4%	15.2%	11.8%
Industry median	7.4%	58.9%	5.2%	-5.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity3 B $45%
Current Liabilities2.2 B $34%
Long-term Liabilities1.5 B $22%

Key Figures

YoY change

Total Assets6.6 B $-1.8%

Total Liabilities3.7 B $-18.0%

Total Equity3 B $+30.5%

Cash & ST Investments2.4 B $-10.6%

Total Debt1.4 B $-46.4%

Net Debt266.6 M $-84.1%

Peer Comparison· Medical Devices

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
DXCM	1.95	46.8%	-0.70	44.6%
PHIA	1.32	71.1%	2.03	41.8%
SHL	1.10	84.1%	3.04	40.6%
COH	2.46	22.1%	0.42	69.4%
4DX	6.57	-22.6%	0.71	-20.4%
Industry median	3.28	44.7%	0.82	49.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
DXCM	1.95	46.8%	-0.70	44.6%
GEHC	1.17	99.1%	2.44	28.7%
STE	2.09	29.1%	0.90	66.9%
ZBH	1.73	59.0%	3.19	55.8%
EW	4.42	6.8%	-2.09	77.5%
PEN	6.02	14.7%	-0.11	77.6%
Industry median	3.28	44.7%	0.82	49.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow1.8 B $+84.9%

Capital Expenditures353.1 M $-9.2%

Free Cash Flow1.4 B $+148.5%

Dividends Paid——

Peer Comparison· Medical Devices

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
DXCM	37.0%	29.7%	7.3%	191.6%
PHIA	13.0%	10.8%	2.2%	236.4%
SHL	12.2%	8.7%	3.5%	134.0%
COH	11.2%	8.5%	2.7%	76.6%
4DX	-761.6%	-530.7%	3.7%	20.7%
Industry median	7.2%	1.5%	4.1%	76.6%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
DXCM	37.0%	29.7%	7.3%	191.6%
GEHC	10.2%	7.6%	2.5%	134.8%
STE	22.6%	16.4%	6.2%	171.4%
ZBH	19.9%	21.8%	4.7%	219.8%
EW	21.6%	17.3%	4.3%	124.3%
PEN	19.0%	14.6%	4.4%	161.7%
Industry median	7.2%	1.5%	4.1%	76.6%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on DXCM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.